Article ID Journal Published Year Pages File Type
10053023 The Journal of Urology 2005 4 Pages PDF
Abstract
Permixon increased molecular markers involved in the apoptotic process, ie the Bax-to-Bcl-2 expression ratio and caspase-3 activity. This could have clinical relevance due to the improvement in symptoms produced by treatment with this drug.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Nephrology
Preview
SERENOA REPENS TREATMENT MODIFIES BAX/BCL-2 INDEX EXPRESSION AND CASPASE-3 ACTIVITY IN PROSTATIC TISSUE FROM PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
Authors
, , , , , ,